Chikungunya vaccine update: Experimental adjuvant-free particles aim to prevent months of joint pain
Short excerpt below. Click through to read at the original source.
Griffith University researchers are on the cusp of a new vaccine to prevent chikungunya, a global health threat which attacks human joint tissue. Professor Bernd Rehm, from Griffith’s Institute for Biomedicine and Glycomics, said his team wanted to test whether they could engineer E.coli to assemble biopolymer particles which displayed chikungunya antigens and performed as […]